Related Experiment Video
Updated: Nov 28, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure
Youngjin Cho1, Sang Yeong Cho1, Il Young Oh1
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Insights
Implantable cardioverter-defibrillators (ICDs) are under-utilized in Korean heart failure patients with reduced ejection fraction. However, ICD use was associated with significantly lower mortality, suggesting a survival benefit in this population.
Area of Science:
- Cardiology
- Medical Devices
- Public Health
Background:
- Limited data exists on implantable cardioverter-defibrillator (ICD) utilization and benefits in Korean patients with heart failure and reduced left ventricular ejection fraction (LVEF).
- A multicenter registry study was conducted to address this data gap.
Purpose of the Study:
- To evaluate the utilization rate of ICDs in Korean patients with heart failure and reduced LVEF.
- To assess the impact of ICD implantation on all-cause mortality in this patient group.
Main Methods:
- A cohort of 485 acute heart failure patients with LVEF ≤ 35% was identified from 10 Korean tertiary hospitals.
- ICD implantation during follow-up was assessed, and mortality was compared between ICD recipients and matched controls.
Main Results:
- Only 11.5% of eligible patients received an ICD, indicating significant under-utilization.
- Patients with ICDs demonstrated significantly lower all-cause mortality compared to controls (adjusted HR = 0.39; P = 0.032).
- This survival benefit persisted after excluding patients with cardiac resynchronization therapy and was particularly notable in ischemic heart failure.
Conclusions:
- The study highlights a substantial under-utilization of ICDs in Korean heart failure patients with reduced LVEF.
- Findings suggest that the survival benefits of ICDs observed in clinical trials can likely be extrapolated to the Korean population.
- Further research and clinical practice adjustments are warranted to optimize ICD use in this demographic.
Background:
There are sparse data on the utilization rate of implantable cardioverter-defibrillator (ICD) and its beneficial effects in Korean patients with heart failure with reduced left ventricular ejection fraction (LVEF).
Methods:
Among 5,625 acute heart failure (AHF) patients from 10 tertiary university hospitals across Korea, 485 patients with reassessed LVEF ≤ 35% at least 3 months after the index admission were enrolled in this study. The ICD implantation during the follow-up was evaluated. Mortality was compared between patients with ICDs and age-, sex-, and follow-up duration matched control patients.
Results:
Among 485 patients potentially indicated for an ICD for primary prevention, only 56 patients (11.5%) underwent ICD implantation during the follow-up. Patients with ICD showed a significantly lower all-cause mortality compared with their matched control population: adjusted hazard ratio (HR) (95% confidence interval [CI]) = 0.39 (0.16-0.92), P = 0.032. The mortality rate was still lower in the ICD group after excluding patients with cardiac resynchronization therapy (adjusted HR [95% CI] = 0.09 [0.01-0.63], P = 0.015). According to the subgroup analysis for ischemic heart failure, there was a significantly lower all-cause mortality in the ICD group than in the no-ICD group (HR [95% CI] = 0.20 [0.06-0.72], P = 0.013), with a borderline statistical significance (interaction P = 0.069).
Conclusion:
Follow-up data of this large, multicenter registry suggests a significant under-utilization of ICD in Korean heart failure patients with reduced LVEF. Survival analysis implies that previously proven survival benefit of ICD in clinical trials could be extrapolated to Korean patients.
Trial Registration:
ClinicalTrials.gov Identifier: NCT01389843.
More Related Videos
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation III: AED Use
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies